Pharmaceuticals News and Research

RSS

New clinical trial to assess antiretroviral treatment in HIV-infected individuals based on CD4 counts

A major new clinical trial seeks to determine whether HIV-infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later, based on their level of CD4+ T-cells.

8 Mar 2011

UCSF's new pharmacy to focus on direct patient care

Although it won't be obvious to UCSF Medical Center patients, behind the scenes a family of giant robots now counts and processes their medications. With a new automated hospital pharmacy, believed to be the nation's most comprehensive, UCSF is using robotic technology and electronics to prepare and track medications with the goal of improving patient safety.

8 Mar 2011

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, announced today the successful completion of its initial in vitro permeation study for its transdermal pain patch project.

8 Mar 2011

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

RainDance Technologies, Inc. and Ambry Genetics, today announced a new collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion genetic screening panel for use on next-generation sequencing systems.

8 Mar 2011

Prevalence of bipolar disorder

Bipolar disorder is a psychiatric disorder that swings between depression and mania. It strikes early and can cause lifelong disability. Reports show that it is chronically undertreated in many low-income countries.

7 Mar 2011

New concerns over prescription narcotics use

Over fifty Australian general practitioners have come under the scanner as part of a national crackdown on inappropriate prescribing of narcotics. The three-month campaign is being carried out by the Medicare following high levels of prescriptions for drugs such as OxyContin and OxyNorm. One GP has been found to be writing over 90 per cent of their prescriptions for narcotics. There are further concerns that the painkillers are being resold on the black market.

7 Mar 2011

Aerie Pharmaceuticals closes $30 million Series B financing

Aerie Pharmaceuticals, Inc, a biotechnology company focused on the discovery and development of medical innovations in ophthalmology, today announced the closing of a $30 million Series B financing.

7 Mar 2011

Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product

ZIOPHARM Oncology, Inc., an oncology small molecule and synthetic biology drug development company, and Solasia Pharma K.K., a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today that they have entered into a license and collaboration agreement to develop and commercialize ZIOPHARM's darinaparsin product and related organic arsenic molecules in specified Pan-Asian/Pacific territories.

7 Mar 2011

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus.

7 Mar 2011

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics, said the company had been granted a US patent for Sym004 as well as other antibody compositions containing at least two distinct anti-EGFR antibodies having certain binding characteristics.

7 Mar 2011

Galderma, Astrazeneca collaborate to develop new compounds for dermatological disorders

AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.

7 Mar 2011

Launch Excellence Services provides solutions to new pharma product market entry

The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.

7 Mar 2011

FDA's action impacts Elite pharma drugs

Elite Pharmaceuticals, Inc. advises that the US Food and Drug Administration announced that it intends to remove approximately 500 cough/cold and allergy related products from the U.S. market.

7 Mar 2011

Plant distillation waste can increase yield, essential oil content in peppermint, spearmint

When essential oils are extracted from plants through the process of steam distillation, wastewater is produced and subsequently released into rivers and streams. Finding new uses for these unused by-products could benefit essential oil crop growers and processors as well as the environment.

7 Mar 2011

Mintz Levin's Health Law Practice to sponsor WBL's 10th Annual Summit

The Health Law Practice of Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. is a sponsor of the Women Business Leaders of the U.S. Health Care Industry Foundation and WBL's 10th Annual Summit.

5 Mar 2011

Mangrove Partners comments that its analysis inaccurately portrayed in CPEX's letter to stockholders

Mangrove Partners, owners of 149,373 shares representing approximately 5.71% of the outstanding shares of CPEX Pharmaceuticals, Inc, believes its analysis and intentions were inaccurately portrayed in CPEX's March 2, 2011 letter to stockholders, which appears to use scare tactics in order to pressure stockholders into accepting an inadequate price for their shares.

5 Mar 2011

NCRM, CSCRM to become national force in regenerative medicine

In a move to streamline and accelerate the research and development of new stem cell and regenerative medicine technologies, the National Center for Regenerative Medicine and the Center for Stem Cell and Regenerative Medicine at Case Western Reserve University have been rolled into a single entity housed within the university's School of Medicine.

5 Mar 2011

Angiotech extends offer to exchange new senior floating rate notes for Existing Floating Rate Notes

Angiotech Pharmaceuticals, Inc. today announced that it has extended its offer to exchange new senior floating rate notes due 2013 for all of its outstanding Senior Floating Rate Notes due 2013 to 11:59 p.m. New York City time on March 30, 2011.

5 Mar 2011

Elsevier / Gold Standard announces enhancements to ProspectoRx

Elsevier / Gold Standard, a leading developer of drug databases and medication management solutions, announced today several enhancements to its pricing tool, ProspectoRx, including the addition of Federal Supply Schedule pricing to facilitate pricing analysis.

5 Mar 2011

CDI announces publication of footprint-free iPSCs production method in PLoS ONE journal

Cellular Dynamics International, the world's largest producer of human tissue cells for drug discovery and safety testing, today announced the publication of research demonstrating an efficient and scalable method of creating DNA integration-free, or footprint-free, induced pluripotent stem cells under a feeder-free condition using chemically defined media.

5 Mar 2011

Pharmaceuticals News and Research

New clinical trial to assess antiretroviral treatment in HIV-infected individuals based on CD4 counts

UCSF's new pharmacy to focus on direct patient care

Alliqua completes transdermal pain patch initial in vitro study for treatment of PHN

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

Prevalence of bipolar disorder

New concerns over prescription narcotics use

Aerie Pharmaceuticals closes $30 million Series B financing

Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product

Inovio initiates VGX-3100 Phase II trial in patients with cervical cancer

USPTO grants patent to Symphogen's Sym004 to treat solid tumors

Galderma, Astrazeneca collaborate to develop new compounds for dermatological disorders

Launch Excellence Services provides solutions to new pharma product market entry

FDA's action impacts Elite pharma drugs

Plant distillation waste can increase yield, essential oil content in peppermint, spearmint

Mintz Levin's Health Law Practice to sponsor WBL's 10th Annual Summit

Mangrove Partners comments that its analysis inaccurately portrayed in CPEX's letter to stockholders

NCRM, CSCRM to become national force in regenerative medicine

Angiotech extends offer to exchange new senior floating rate notes for Existing Floating Rate Notes

Elsevier / Gold Standard announces enhancements to ProspectoRx

CDI announces publication of footprint-free iPSCs production method in PLoS ONE journal

Event guide: 3rd EHS for Biopharma Summit eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence